Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02417077 · ClinicalTrials.gov registry record
Perception of Facial Expression in Subjects With and Without Crow's Feet Lines
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 393
- Enrollment target
NCT02417077: Completed study, sponsored by Allergan.
NCT02417077 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 393 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02417077 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 393 participants
- Enrollment target
Study Summary
This study will examine the perception of facial expressions among individuals with and without crow's feet lines.
Interventions
- OTHER Photographic Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 393 participants |
| Start Date | 2015-12 |
| Est. Completion | 2015-12 |
What the finished NCT02417077 record still lists
NCT02417077 is an observational study that tracks outcomes without assigning an intervention. The registered 393 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Photographic Review is the first listed.
NCT02417077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02417077 about?
NCT02417077 is a clinical study titled "Perception of Facial Expression in Subjects With and Without Crow's Feet Lines". This study will examine the perception of facial expressions among individuals with and without crow's feet lines.
What is the current status of trial NCT02417077?
This trial is currently completed. The enrollment target is 393 participants. The study started on 2015-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02417077?
The interventions under investigation include: Photographic Review (OTHER).
Who is sponsoring clinical trial NCT02417077?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- NCT06613698 · 393 participants · Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia